SILO Silo Pharma, Inc.
Fundamentals / CIK 0001514183 / USDSilo Pharma, Inc. reported $36K in revenue and a net loss of $3.72M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a 77.1% gross margin and a -12534.1% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SILO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$36K -100.0% YoY
-
Operating Income TTM-$4.52M -12534.1% margin
-
Net Income TTM-$3.72M -10319.0% net margin
-
Diluted EPS TTM-$2.13 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$8.05M Total debt: --
Annual revenue and net income
10 fiscal years (2012 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72K | $72K | $72K | $72K | -- | $41K | $41K | -- | -- | -- |
| Cost of Revenue | $44K | $5.8K | $5.8K | $5.8K | $5.0K | $176K | $27K | -- | -- | -- |
| Gross Profit | $28K | $66K | $66K | $66K | $66K | -$135K | $13K | -- | -- | -- |
| Research & Development | $2.16M | $2.37M | $845K | $1.29M | $694K | $26K | -- | -- | -- | -- |
| Selling, General & Admin | -- | -- | $390K | $227K | $163K | $50K | -- | -- | -- | -- |
| Total Operating Expenses | $4.31M | $4.77M | $3.92M | $3.69M | $2.81M | $2.20M | $944K | $594K | $491K | -- |
| Operating Income | -$4.28M | -$4.71M | -$3.86M | -$3.63M | -$2.74M | -$2.20M | -$930K | -$594K | -$491K | -- |
| Interest Income | $207 | $333K | $399K | $73K | $1.2K | $12K | -- | -- | -- | -- |
| Interest Expense | $37K | $5.1K | $4.9K | $2.2K | $3.0K | $80 | $0 | -- | -- | -- |
| Income Before Tax | -$4.23M | -$4.39M | -$3.63M | -$3.91M | $4.18M | -$2.67M | -- | -- | -- | -- |
| Income Tax Expense | -- | -- | -- | -- | $25K | -- | -- | -- | -- | -- |
| Net Income | -$4.23M | -$4.39M | -$3.70M | -$3.91M | $3.90M | -$3.04M | -$1.01M | -$969K | $357K | -$39K |
| Basic EPS | -$7.50 | -$17.85 | -$18.00 | -- | $30.00 | -$37.50 | -$30.00 | -$15.00 | $7.50 | $0.00 |
| Diluted EPS | -$7.50 | -$17.85 | -$18.00 | -- | $30.00 | -$37.50 | -$30.00 | -$15.00 | $7.50 | $0.00 |
| Basic Shares Outstanding | 558.8K | 245.4K | 205.3K | 152.3K | 126.5K | 87.9K | 31.3K | 65.5K | -- | 40.8K |
| Diluted Shares Outstanding | 558.8K | 245.4K | 205.3K | 152.3K | 127.9K | 87.9K | 31.3K | 65.5K | 69.4K | 40.8K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $18K | $18K | $18K | $18K | $18K | $18K |
| Cost of Revenue | -- | $0 | $21K | $21K | $21K | $1.5K | $1.5K | $1.5K |
| Gross Profit | -- | $0 | -$2.7K | -$2.7K | -$2.7K | $17K | $17K | $17K |
| Research & Development | $559K | $298K | $1.01M | $306K | $544K | $717K | $594K | $1.08M |
| Total Operating Expenses | $1.21M | $929K | $1.59M | $760K | $1.17M | $1.27M | $1.11M | $1.83M |
| Operating Income | -$1.21M | -$929K | -$1.59M | -$787K | -$1.15M | -$1.25M | -$1.09M | -$1.81M |
| Interest Income | $16 | $1.1K | $191 | $43K | $45K | $45K | $62K | $83K |
| Interest Expense | $1.1K | $2.9K | $3.4K | $33K | $886 | $1.6K | $2.1K | $274 |
| Income Before Tax | -$359K | -$833K | -$1.65M | -$882K | -$1.11M | -$1.20M | -$1.03M | -$1.73M |
| Net Income | -$359K | -$833K | -$1.65M | -$882K | -$1.11M | -$1.20M | -$1.03M | -$1.73M |
| Basic EPS | -$0.21 | -$0.76 | -$1.80 | -- | -$1.79 | -$2.88 | -$3.45 | -- |
| Diluted EPS | -$0.21 | -$0.76 | -$1.80 | -- | -$1.79 | -$2.88 | -$3.45 | -- |
| Basic Shares Outstanding | 1.7M | 1.1M | 913.9K | -- | 622.1K | 418.6K | 299.0K | -- |
| Diluted Shares Outstanding | 1.7M | 1.1M | 913.9K | -- | 622.1K | 418.6K | 299.0K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.75M | $3.91M | $3.52M | $11.37M | $9.84M | $1.13M | $112K | $337K | $295K | $2.01M |
| Short-Term Investments | $2.11M | $3.17M | $4.14M | -- | -- | -- | -- | -- | -- | -- |
| Cash & Short-Term Investments | $6.86M | $7.08M | $7.67M | $11.37M | $9.84M | $1.13M | $112K | $337K | $295K | $2.01M |
| Accounts Receivable, Net | -- | -- | -- | $66K | -- | $24K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- | $33K | $156K | $27K | -- | -- |
| Other Current Assets | $99K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $7.39M | $7.11M | $7.68M | $11.57M | $10.40M | $1.43M | $494K | $626K | $1.64M | -- |
| Intangible Assets | $217K | $241K | -- | -- | -- | -- | -- | $29K | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | $61K | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $217K | $300K | $65K | $71K | $88K | $0 | $0 | $229K | $0 | -- |
| Total Assets | $7.61M | $7.41M | $7.75M | $11.64M | $10.49M | $1.43M | $494K | $855K | $1.64M | $2.21M |
| Accounts Payable | $35K | $147K | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $72K | $72K | $72K | $72K | $72K | -- | -- | -- | -- | -- |
| Total Current Liabilities | $650K | $1.66M | $776K | $436K | $490K | $142K | $117K | $48K | $38K | -- |
| Deferred Revenue (Non-Current) | $649K | $722K | $794K | $866K | $938K | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $649K | $722K | $794K | $866K | $938K | $4.2K | $0 | $0 | $0 | -- |
| Total Liabilities | $1.30M | $2.38M | $1.57M | $1.30M | $1.43M | $146K | $117K | $48K | $38K | $19K |
| Common Stock | $89 | $449 | $316 | $316 | $197 | $8.5K | $2.4K | $2.3K | $5.0K | $4.1K |
| Retained Earnings | -$19.49M | -$15.26M | -$10.87M | -$7.17M | -$3.26M | -$5.76M | -$2.66M | -$1.64M | -- | -- |
| Accumulated Other Comp. Income | $5.8K | $2.4K | -$6.2K | -- | -- | -- | -- | -- | -$470K | -- |
| Total Stockholders' Equity | $6.31M | $5.03M | $6.18M | $10.34M | $9.06M | $1.28M | -$23K | $407K | $1.20M | $1.79M |
| Total Equity | $6.31M | $5.03M | $6.18M | $10.34M | $9.06M | $1.28M | -$23K | $407K | $1.20M | $1.79M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $6.09M | $3.28M | $3.90M | $4.75M | $3.92M | $4.33M | $3.14M | $3.91M |
| Short-Term Investments | $1.96M | $1.95M | $2.13M | $2.11M | $1.95M | $1.93M | $2.31M | $3.17M |
| Cash & Short-Term Investments | $8.05M | $5.23M | $6.03M | $6.86M | $5.87M | $6.26M | $5.45M | $7.08M |
| Other Current Assets | -- | -- | $69K | $99K | -- | -- | -- | -- |
| Total Current Assets | $8.59M | $5.71M | $6.80M | $7.39M | $6.16M | $6.37M | $5.60M | $7.11M |
| Intangible Assets | $209K | $212K | $214K | $217K | $220K | $223K | $238K | $241K |
| Total Non-Current Assets | $209K | $238K | $214K | $217K | $220K | $279K | $296K | $300K |
| Total Assets | $8.80M | $5.95M | $7.02M | $7.61M | $6.38M | $6.65M | $5.90M | $7.41M |
| Accounts Payable | -- | -- | -- | $35K | -- | $135K | $97K | $147K |
| Deferred Revenue (Current) | -- | -- | $72K | $72K | $72K | $72K | $72K | $72K |
| Total Current Liabilities | $351K | $1.07M | $705K | $650K | $708K | $1.05M | $1.19M | $1.66M |
| Deferred Revenue (Non-Current) | -- | -- | $631K | $649K | $668K | $686K | $704K | $722K |
| Total Non-Current Liabilities | $0 | $0 | $631K | $649K | $668K | $686K | $704K | $722K |
| Total Liabilities | $351K | $1.07M | $1.34M | $1.30M | $1.38M | $1.74M | $1.89M | $2.38M |
| Common Stock | $191 | $113 | $1.6K | $89 | $1.0K | $865 | $449 | $449 |
| Retained Earnings | -$22.33M | -$21.97M | -$21.14M | -$19.49M | -$18.61M | -$17.50M | -$16.30M | -$15.26M |
| Accumulated Other Comp. Income | $3.2K | $6.8K | $8.7K | $5.8K | $11K | $9.6K | $11K | $2.4K |
| Total Stockholders' Equity | $8.44M | $4.89M | $5.68M | $6.31M | $5.01M | $4.92M | $4.01M | $5.03M |
| Total Equity | $8.44M | $4.89M | $5.68M | $6.31M | $5.01M | $4.92M | $4.01M | $5.03M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.23M | -$4.39M | -$3.70M | -$3.91M | $3.90M | -$3.04M | -$1.01M | -$969K | $357K | -- |
| Stock-Based Compensation | $117K | $907K | $872K | $578K | $395K | $756K | $320K | $145K | $178K | -- |
| Change in Receivables | -- | -- | -$3.6K | -$4.8K | -$1.2K | -- | -- | -- | -- | -- |
| Change in Inventory | -- | -- | -- | -- | -- | -$15K | -$129K | -$27K | -- | -- |
| Operating Cash Flow | -$4.66M | -$3.83M | -$3.22M | -$3.50M | -$2.28M | -$1.16M | -$794K | $273K | -$285K | -$182K |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$180K |
| Investing Cash Flow | $644K | $974K | -$4.15M | $87K | $7.19M | $39K | $187K | -$250K | -- | -- |
| Common Stock Issued | -- | $1.74M | -- | $4.94M | -- | $2.12M | -- | $24K | -- | $2.00M |
| Financing Cash Flow | $4.86M | $3.24M | -$471K | $4.94M | $3.79M | $2.13M | $383K | $19K | -- | $2.19M |
| Net Change in Cash | $843K | $381K | -$7.84M | $1.53M | $8.71M | $1.02M | -$225K | $42K | -$285K | $2.01M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$359K | -$833K | -$1.65M | -$882K | -$1.11M | -$1.20M | -$1.03M | -$1.73M |
| Stock-Based Compensation | $9.4K | $39K | $57K | $52K | $47K | -$161K | $178K | $395K |
| Operating Cash Flow | -$604K | -$782K | -$823K | -$780K | -$955K | -$1.29M | -$1.64M | -$917K |
| Investing Cash Flow | -$17K | $183K | -$24K | -$520K | -$95K | $388K | $871K | -$38K |
| Financing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $0 |
| Net Change in Cash | $2.81M | -$625K | -$846K | $831K | -$416K | $1.20M | -$769K | -$955K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.6% | 91.9% | 91.9% | 91.9% | -- | -330.4% | 32.5% | -- | -- | -- |
| Operating Margin | -5937.0% | -6526.4% | -5347.4% | -5031.3% | -- | -5380.2% | -2293.4% | -- | -- | -- |
| Net Profit Margin | -5863.5% | -6092.6% | -5132.6% | -5420.9% | -- | -7422.5% | -2497.7% | -- | -- | -- |
| Return on Equity (ROE) | -67.0% | -87.3% | -59.9% | -37.8% | 43.1% | -237.2% | -- | -237.9% | 29.6% | -- |
| Return on Assets (ROA) | -55.6% | -59.3% | -47.8% | -33.6% | 37.2% | -212.9% | -205.2% | -113.3% | 21.7% | -14138.4% |
| Current Ratio | 11.36x | 4.29x | 9.90x | 26.52x | 21.23x | 10.07x | 4.23x | 13.05x | 42.81x | 0.01x |
| Quick Ratio | 10.55x | 4.28x | 9.88x | 26.20x | 20.07x | 9.83x | 2.89x | 12.49x | 7.68x | 0.01x |
| Revenue Growth (YoY) | 0.0% | 0.0% | 0.0% | -- | -- | +0.9% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -58.0% | 0.0% | 0.0% | 0.0% | -- | -1125.7% | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -200.1% | -- | -- | -- | -371.9% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -300.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -391.3% | -- | -- | -- |
| 5Y Revenue / Share Growth | -72.3% | -77.3% | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -14.8% | 11.9% | 38.6% | 65.2% | 91.9% | 91.9% | 91.9% |
| Operating Margin | -12534.1% | -8250.5% | -6631.2% | -5937.0% | -7361.1% | -7165.0% | -6824.1% | -6526.4% |
| Net Profit Margin | -10319.0% | -8269.5% | -6717.4% | -5863.5% | -7041.1% | -6789.2% | -6411.3% | -6092.6% |
| Return on Equity (ROE) | -44.1% | -91.5% | -85.2% | -67.0% | -101.4% | -99.6% | -115.2% | -87.3% |
| Return on Assets (ROA) | -42.3% | -75.1% | -69.0% | -55.6% | -79.5% | -73.6% | -78.4% | -59.3% |
| Current Ratio | 24.43x | 5.36x | 9.65x | 11.36x | 8.70x | 6.07x | 4.73x | 4.29x |
| Quick Ratio | 22.91x | 4.90x | 8.56x | 10.55x | 8.28x | 5.96x | 4.60x | 4.28x |
| Revenue Growth (YoY) | -100.0% | -100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross Profit Growth (YoY) | -- | -100.0% | -116.1% | -116.1% | -116.1% | 0.0% | 0.0% | 0.0% |